Identification of crassin acetate as a new immunosuppressant triggering heme oxygenase-1 expression in dendritic cells

Blood

Volumn 114, Issue 1, 2009, Pages 64-73

  Matsushima, Hironori ^a,b   Tanaka, Hiroaki ^a   Mizumoto, Norikatsu ^a   Takashima, Akira ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CONCANAVALIN A; CRASSIN ACETATE; DITERPENOID; HEME OXYGENASE 1; IMMUNOSUPPRESSIVE AGENT; IONOMYCIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; OXAZOLONE; PHORBOL 13 ACETATE 12 MYRISTATE; RUTHENIUM DERIVATIVE; UNCLASSIFIED DRUG; DITERPENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL MIGRATION; CELL STIMULATION; CONTACT DERMATITIS; CONTROLLED STUDY; CORAL; DENDRITIC CELL; DRUG SAFETY; DRUG SCREENING; ENZYME ACTIVITY; EPIDERMIS; FEMALE; GENE EXPRESSION REGULATION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LANGERHANS CELL; LEUKOCYTE ACTIVATION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; T LYMPHOCYTE ACTIVATION; TARGET CELL; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; DNA MICROARRAY; DRUG DEVELOPMENT; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; METABOLISM; MIXED LYMPHOCYTE CULTURE;

ANIMALS; CARBON MONOXIDE; CELL DIFFERENTIATION; DENDRITIC CELLS; DITERPENES; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; FEMALE; GENE EXPRESSION; HEME OXYGENASE-1; IMMUNOSUPPRESSIVE AGENTS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER;

EID: 67651053007     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-02-204297     Document Type: Article

References (41)

1. O'Shea JJ, Pesu M, Borie DC, Changelian PS. A new modality for immunosuppression: targeting the JAK/STAT pathway. Nat Rev Drug Discov. 2004;3:555-564. (Pubitemid 39022985)
2. Taylor AL, Watson CJ, Bradley JA. Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol. 2005;56:23-46.
3. Shlomchik WD. Graft-versus-host disease. Nat Rev Immunol. 2007;7:340-352.
4. Hackstein H, Thomson AW. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol. 2004;4:24-34. (Pubitemid 38084129)
5. Matsue H, Yang C, Matsue K, Edelbaum D, Mummert M, Takashima A. Contrasting impacts of immunosuppressive agents (rapamycin, FK506, cyclosporin A, and dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation. J Immunol. 2002;169:3555-3564.
6. Matsue H, Edelbaum D, Shalhevet D, et al. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J Immunol. 2003;171:3010-3018. (Pubitemid 37093524)
7. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/ carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 2006;86:583-650.
8. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A. 1997;94:10925-10930. (Pubitemid 27430837)
9. Yet SF, Perrella MA, Layne MD, et al. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest. 1999;103:R23-R29.
10. Yachie A, Niida Y, Wada T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999;103:129-135. (Pubitemid 29031171)
11. Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003;24: 449-455. (Pubitemid 36928103)
12. Kim HP, Ryter SW, Choi AM. CO as a cellular signaling molecule. Annu Rev Pharmacol Toxicol. 2006;46:411-449.
13. Mizumoto N, Gao J, Matsushima H, Ogawa Y, Tanaka H, Takashima A. Discovery of novel immunostimulants by dendritic-cell-based functional screening. Blood. 2005;106:3082-3089. (Pubitemid 41565904)
14. Mizumoto N, Kumamoto T, Robson SC, et al. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med. 2002;8:358-365. (Pubitemid 34407030)
15. Ciereszko LS, Sifford DH, Weinheimer AJ. Chemistry of coelenterates. I. Occurrence of terpenoid compounds in gorgonians. Ann N Y Acad Sci. 1960;90:917-919.
16. Weinheimer AJ, Matson JA. Crassin acetate, the principal antineoplastic agent in four gorgonians of the Pseudoplexaura genus. Lloydia. 1975;38: 378-382.
17. Burres NS, Hunter JE, Wright AE. A mammalian cell agar-diffusion assay for the detection of toxic compounds. J Nat Prod. 1989;52:522-527.
18. Rodriguez AD, Martinez N. Marine antitumor agents: 14-deoxycrassin and pseudoplexaurol, new cembranoid diterpenes from the Caribbean gorgonian Pseudoplexaura porosa. Experientia. 1993;49:179-181. (Pubitemid 23063423)
19. Hann RM, Pagan OR, Gregory L, et al. Characterization of cembranoid interaction with the nicotinic acetylcholine receptor. J Pharmacol Exp Ther. 1998;287:253-260. (Pubitemid 29140209)
20. Pagan OR, Eterovic VA, Garcia M, et al. Cembranoid and long-chain alkanol sites on the nicotinic acetylcholine receptor and their allosteric interaction. Biochemistry. 2001;40:11121-11130. (Pubitemid 32847980)
21. Li P, Reichert DE, Rodriguez AD, et al. Mechanisms of potentiation of the mammalian GABAA receptor by the marine cembranoid eupalmerin acetate. Br J Pharmacol. 2008;153:598-608. (Pubitemid 351199023)
22. Chauveau C, Remy S, Royer PJ, et al. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood. 2005;106:1694-1702. (Pubitemid 41208583)
23. Chora AA, Fontoura P, Cunha A, et al. Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J Clin Invest. 2007; 117:438-447. (Pubitemid 46203972)
24. Li M, Peterson S, Husney D, et al. Interdiction of the diabetic state in NOD mice by sustained induction of heme oxygenase: possible role of carbon monoxide and bilirubin. Antioxid Redox Signal. 2007;9:855-863. (Pubitemid 46919588)
25. Li M, Peterson S, Husney D, et al. Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice. Cell Cycle. 2007;6:567-571. (Pubitemid 46440429)
26. Pae HO, Oh GS, Choi BM, et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol. 2004;172:4744-4751.
27. McDaid J, Yamashita K, Chora A, et al. Heme oxygenase-1 modulates the allo-immune response by promoting activation-induced cell death of T cells. FASEB J. 2005;19:458-460. (Pubitemid 40316549)
28. Choi BM, Pae HO, Jeong YR, Kim YM, Chung HT. Critical role of heme oxygenase-1 in Foxp3- mediated immune suppression. Biochem Biophys Res Commun. 2005;327:1066-1071.
29. + T cells. Biochem Biophys Res Commun. 2003;306:701-705.
30. Piantadosi CA. Carbon monoxide, reactive oxygen signaling, and oxidative stress. Free Radical Biol Med. 2008;45:562-569.
31. Foresti R, Bani-Hani MG, Motterlini R. Use of carbon monoxide as a therapeutic agent: promises and challenges. Intensive Care Med. 2008;34: 649-658.
32. Kaplan DH, Kissenpfennig A, Clausen BE. Insights into Langerhans cell function from Langerhans cell ablation models. Eur J Immunol. 2008; 38:2369-2376.
33. Sasaki Y, Aiba S. Dendritic cells and contact dermatitis. Clin Rev Allergy Immunol. 2007;33:27-34.
34. Dieu MC, Vanbervliet B, Vicari A, et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med. 1998;188:373-386. (Pubitemid 28357765)
35. Hu CM, Lin HH, Chiang MT, Chang PF, Chau LY. Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in NOD mice. Diabetes. 2007;56:1240-1247. (Pubitemid 46715603)
36. Woo J, Iyer S, Cornejo MC, et al. Stress proteininduced immunosuppression: inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32). Transpl Immunol. 1998;6:84-93. (Pubitemid 28454330)
37. Araujo JA, Meng L, Tward AD, et al. Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse. J Immunol. 2003;171: 1572-1580. (Pubitemid 36900093)
38. Honda T, Gribble GW, Suh N, et al. Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophages. J Med Chem. 2000;43:1866-1877. (Pubitemid 30305019)
39. Dinkova-Kostova AT, Liby KT, Stephenson KK, et al. Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proc Natl Acad Sci U S A. 2005;102:4584-4589.
40. Visner GA, Lu F, Zhou H, Liu J, Kazemfar K, Agarwal A. Rapamycin induces heme oxygenase- 1 in human pulmonary vascular cells: implications in the antiproliferative response to rapamycin. Circulation. 2003;107:911-916. (Pubitemid 36241052)
41. Schmidt R. Cobalt protoporphyrin as a potential therapeutic agent? FASEB J. 2007;21:2639-2640. (Pubitemid 47372767)